Berhan Public Health and Eye Care Consultancy PLC Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01949454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Berhan Public Health and Eye Care Consultancy PLC | Berhan Public Health & Eye Care Consultancy PLC

Active Ingredients

Drugs in Phase 4 Trials (1)

fluorometholone (fml) (2 trials)

Drugs in Other Trials (1)

methylcellulose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eye Diseases (Phase 4)

Eyelid Diseases (Phase 4)

Trichiasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2